Toggle navigation
COVID-19
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
2023 Debates and Didactics in Hematology and Oncology Conference
IASLC 2023 World Conference on Lung Cancer
2023 ASCO Breakthrough Meeting
EHA Hybrid Congress 2023
ESMO Breast Cancer Annual Congress 2023
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
The ASCO Post Roundtable Series
present case-based, tumor-specific discussions on the latest developments in cancer care. Join key experts in oncology as they discuss the management of challenging clinical scenarios in oncology.
New Directions in Metastatic Colorectal Cancer
Novel Therapies for Advanced Breast Cancer
Clinical Advances in Diffuse Large B-Cell Lymphoma
Treatment Considerations in Renal Cell Carcinoma
Updates in Myeloproliferative Neoplasms
Clinical Advances in Mantle Cell Lymphoma
Advances in Follicular Lymphoma
Novel Hormonal Therapies for Prostate Cancer
The Evolving Treatment Landscape for Colorectal Cancer
Clinical Considerations in Chronic Graft-vs-Host Disease
Updates in Melanoma
Updates in Hepatobiliary Cancer
Updates in Renal Cell Carcinoma
Updates in Colorectal Cancer
Updates in HER2-Positive Breast Cancer
Updates in Lymphoma
Updates in Prostate Cancer (1)
Updates in Acute Myeloid Leukemia
Updates in Lung Cancer
Updates in Breast Cancer
Updates in Prostate Cancer
Updates in Gynecologic Oncology
Appropriate Management of Challenging Cases in Lung Cancer
Appropriate Management of Challenging Cases in Myeloma and Lymphoma
Advertisement
Advertisement
Oct
03
Today In Oncology
Relapsed or Refractory Multiple Myeloma Mezigdomide Plus Dexamethasone
Allogeneic HCT Outcomes in Patients With MDS and High-Risk Genetics
FDA Grants First Marketing Authorization for a DNA Test to Assess Predisposition for Dozens of Cancer Types
Tucatinib/Trastuzumab for Previously Treated Patients With HER2-Positive Metastatic Biliary Tract Cancer
Prophylactic Radiation for High-Risk Asymptomatic Bone Metastases
View More
Advertisement